Image

Effectiveness of Visceral Manual Therapy in Bruxist Patients With Gastroesophageal Reflux

Effectiveness of Visceral Manual Therapy in Bruxist Patients With Gastroesophageal Reflux

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Objective: check the effectiveness of visceral manual therapy on bruxist patients with gastroesophageal reflux.

Design: Experimental, analytical, longitudinal, prospective, randomized, single-blind study with a blinded evaluator.

Subjects: 68 subjects over 18 years old, with bruxism (diagnoses by a dentist) and gastroesophageal reflux (evidenced by the GERDQ test).

Methods: Subjects will be randomized into 2 groups: an experimental group (EG) to which a visceral manual technique will be applied and a control group (CG) to which a placebo manual technique will be administered. Both groups will receive 2 interventions one week apart. The measurements will be made before and after the interventions, and a last measurement will be made one month after the last intervention. Therefore, the patient will visit the center 3 times.

Eligibility

Inclusion Criteria:

  • Subjects with bruxism diagnosed and referred by a dentist
  • Subjects with gastroesophageal reflux: score >8 in the GerdQ test.
  • Age: older than 18 years-old.

Exclusion Criteria:

  • Recent craniofacial, mandibular or cervical trauma or fracture.
  • Temporomandibular joint surgery.
  • Acute pain due to other components of the masticatory system (caries, inflammation of the dental root).
  • Abdominal surgery.
  • Gastric ulcers.
  • Gastritis.
  • Previous or current gastric neoplasm.
  • Neurological or systemic diseases.
  • Pregnant, including the period of breastfeeding.
  • Patients receiving chemotherapy or radiotherapy.
  • Cognitive, psychosomatic or psychiatric illnesses that may affect the data obtained.
  • Basic systemic disease of rheumatic origin (for example, arthritis, osteoarthritis, gout and psoriasis).
  • Cerebrovascular and brain diseases.
  • Arrhythmia and other cardiac problems.
  • Implanted electronic devices.
  • Drug or alcohol abuse, analgesic or sedative therapy, and use of medications that affect the central nervous system (for example, antidepressants, anxiolytics, and anticonvulsants).
  • Patients who have previous experience with manual treatment of the diaphragm

Study details
    Bruxism
    Gastroesophageal Reflux

NCT05751694

University of Seville

27 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.